Search
Now showing items 1-10 of 48
Immature spermatids are not prevalent in semen from men who are receiving androgen-based contraceptive regimens
(Elsevier, 1998-01)
OBJECTIVE: To determine whether immature spermatids increase in semen in
response to hormonal contraceptive treatments. Such a finding would
support the existence of a defect in spermiogenesis, which in turn may
explain the reported variability in sperm output. DESIGN: Semen smears
were obtained ...
A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men
(Endocrine Society, 1999-10)
This is a pilot dose-finding study of spermatogenic suppression using
testosterone undecanoate (TU) injections alone in normal Chinese men.
Thirty-two healthy men were recruited. Volunteers underwent pretreatment
evaluation, then a treatment period in which group I (n = 13) received 500
mg TU, group ...
Quantitative (stereological) study of the normal spermatogenesis in the adult monkey (Macaca fascicularis)
(American Society of Andrology, 1997-11)
Germ cell and Sertoli cell numbers were estimated in six normal adult
monkeys (Macaca fascicularis) using a contemporary unbiased and efficient
stereological method--the optical disector. The data was used to assess
the efficiency of spermatogenesis from type B spermatogonia to elongated
spermatids. ...
The anterior pituitary response to a gonadotropin-releasing hormone challenge test in normal older reproductive-age women
(Elsevier, 1996-03)
OBJECTIVE: To assess the pituitary responsiveness to GnRH stimulation of
premenopausal women relative to age. DESIGN: Older and younger
reproductive-age women underwent the GnRH stimulation test in the early
follicular phase of the menstrual cycle. SETTING: Female subjects in an
academic research ...
Effects of aging on menstrual cycle hormones and endometrial maturation
(Elsevier, 1995-09)
OBJECTIVE: To investigate changes in menstrual cycle hormones and
endometrial maturation that may contribute to the decline in fertility
with aging. DESIGN: Prospective controlled clinical study. SETTING: Normal
human volunteers in an academic research institution. SUBJECTS: Women with
regular ...
Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach
(Endocrine Society, 1996-02)
Studies using high dose testosterone (T) administration in normal men as a
male contraceptive have resulted in azoospermia rates of only 50-70%.
Previous studies of T and progestogen combinations have shown comparable
rates of azoospermia, but have been uncontrolled or used T in doses less
than ...
Follistatin decreases activin-stimulated FSH secretion with no effect on GnRH-stimulated FSH secretion in prepubertal male monkeys
(Endocrine Society, 1994-04)
Follistatin is an activin-binding glycoprotein that decreases FSH
secretion in vitro and in vivo in rats. The mechanism by which follistatin
acts is unclear, but it has been suggested that it may bind endogenous
activin and neutralize its effects. In this study, we wished to test the
ability of ...
Prostate-sparing effects in primates of the potent androgen 7alpha-methyl-19-nortestosterone: a potential alternative to testosterone for androgen replacement and male contraception
(Endocrine Society, 1998-12)
7alpha-Methyl-19-nortestosterone (MENT) is a potent synthetic androgen
that cannot be converted to dihydrotestosterone. In this study we
determined the relative androgenic, antigonadotropic, and anabolic
potencies of testosterone vs. MENT in the nonhuman primate M.
fascicularis. In castrated monkeys, ...
Serum inhibin levels during the periovulatory interval in normal women: relationships with sex steroid and gonadotrophin levels
(Blackwell Publishing, 1990-01)
Inhibin is a gonadal glycoprotein believed to be important in the
regulation of pituitary FSH secretion and/or to function as a paracrine
factor within the ovary and testis. We studied serum levels of inhibin,
oestradiol (E2), progesterone (P), FSH and LH during the periovulatory
interval in order ...
Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive
(Endocrine Society, 1991-09)
No effective hormonal contraceptive has yet been devised for men. Through
their suppressive effect on gonadotropin secretion, GnRH antagonists
inhibit both testosterone (T) production and spermatogenesis in animals.
Long term administration of an antagonist alone would result in androgen
deficiency; ...